Trial intelligence / Profile preview

Dexamethasone for Pain in Outpatient Knee Surgery

NCT01149616Phase 4Terminated

Sponsor
Beth Israel Deaconess Medical Center
Start
Dec 2009
Primary completion
Dec 2012
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of dexamethasone in postoperative pain and postoperative nausea and vomiting (PONV) (2 arms), sponsored by Beth Israel Deaconess Medical Center. Primary endpoint: Post Operative VAS Pain Scale at 24 hours. Started Dec 2009; status: terminated.

02

Drugs

dexamethasone
03

Conditions

postoperative painpostoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on NCT01149616.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01149616.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call